The Swiss drugmaker will pay $1.1 billion upfront and up to $400 million in milestones to gain a novel antibody-drug ...

(KRON) — A Bay Area-based biotechnology giant is laying off more than 100 employees, according to a new Worker Adjustment and ...

Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...

Scientists pieced together the genetic history of Acinetobacter baumannii — a notoriously stubborn hospital pathogen — using ...

The Australian Securities Exchange underperformed its international peers by a long shot in the past year, but some sectors ...

House committee launches investigation into Eli Lilly's China clinical trials at military hospitals and Xinjiang facilities, ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.

Officials at Elsevier say the company is expanding LeapSpace, a research-grade AI workspace, with new agentic capabilities.

Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer’s, unlike many names in the ...